Announced Sat, 30 May · 23:55 IST

Approval of audited financial results for the quarter and year ended 31st March 2026

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-3.8%1-day move
₹106.00
prior close
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-3.8+1.8-2.7+9.0-0.9+0.7-2.0-3.8
Up moveDown movePending
AI summary

The Board of Directors of Sharma East India Hospitals & Medical Research Ltd approved the IND-AS compliant standalone audited financial results for Q4 and the full year ended 31st March 2026. The meeting was held on 30th May 2026. The Board also approved the standalone statement of assets and liabilities and the cashflow statement for the same period. A key highlight is the declaration of an unmodified (clean) audit opinion from the statutory auditors for FY 2025-26, indicating no concerns about the company's financial statements.

Likely market impact

An unmodified audit opinion is a positive signal for investors, confirming financial health and transparency. No red flags such as going concern doubts or qualifications were raised by auditors for this hospital and medical research company.